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Summary The aim of this study was to elucidate the effects of dietary vitamin A and E supplementation on
tumorigenesis in correlation to the fat content of the respective diet in an animal model. One hundred and
twenty female SD rats were initiated intravenously with 25 mg MNUkg on day 50 of life. For a period of 6
months, beginning after the day of initiation, all animals received a semisynthetic diet containing 25% or 45%
of the energy as fat, supplemented either with a 10-fold higher amount of naturally occurring vitamins A and
E than in rat standard diets or, with a normal level of these vitamins.
The experiment showed: (1) Vitamin A and E supplementation showed no significant chemopreventive
effect against mammary tumour development. (2) This result was independent from the supplied fat level of
the respective diet. (3) The fat content per se did not significantly influence mammary tumorigenesis.
In the last few years there has been a growing interest in the
concept of cancer chemoprevention. The activities of several
agents that appear to be useful in chemoprevention have
been characterized, and there are continuing efforts to
identify additional compounds, either of natural occurrence
or synthetic, that can specifically inhibit the process of
carcinogenesis.
During the early stages in the evolution of many
neoplasms, metaplasia occurs. The normal differentiation
pattern of the respective tissue is lost and a new form of
epithelium appears. A deficiency of vitamin A, an essential
agent to regulate cell proliferation and differentiation, results
in metaplasia also (Cohen et al., 1976; Lotan, 1980; Moon et
al., 1983).
Experimental studies have indicated that insufficient
dietary levels of vitamin A may be related to an increased
susceptibility to carcinogen induced cancer of the stomach,
nasopharynx, lower respiratory tract and endocervix (Moon
et al., 1983; Romppanen et al., 1985). Furthermore, there is
evidence from some experimental results, that an increased
intake of vitamin A or its synthetic analogues inhibits
dimethylbenz(a)anthracene (DMBA)- (Clayson, 1975;
McCormick et al., 1980; Stone et al., 1984), methyl-
nitrosourea (MNU)- (Moon et al., 1977; Welsch et al., 1980;
Moon et al., 1983; McCormick & Moon, 1982), and
benzo(a)pyrene- (McCormick et al., 1981) induced rat
mammary tumour development. The utility of vitamin A as
an anticarcinogenic treatment, however, is contested in view
of some experimental studies resulting in a zero effect
(Schmahl et al., 1972; Schmahl & Habs, 1978; Thompson &
Ronan, 1983), or even an opposite effect (Polliack & Levij,
1969; Quander et al., 1985), and in view of epidemiological
findings. In man natural retinoids appeared to be associated
with a lower risk of cancer of the lung (Shekelle et al., 1981),
urinary bladder, mouth, larynx, cervix, and to a lesser extent
also of the breast (Kark et al., 1981; Graham, 1984). One
connecting link between all these tumours is their epithelial
origin. Howeverm a higher risk from elevated retinoid levels
was reported for prostate cancer, leukaemia and Hodgkin's
disease (Graham, 1984).
Vitamin E (ac-tocopherol) acts as a biological antioxidant
inhibiting lipid peroxidation, and thus protects cell
membranes and possibly nucleic acids against oxidative
damage. Of the various tocopherols, vitamin E is most
widely distributed among different foods (particularly vege-
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table oils, whole grain cereal products, and eggs), which
causes some difficulties for epidemiological research to
identify population groups with substantially different levels
of intake (Newberne & Suphakarn, 1983). The influence of
vitamin E on carcinogenesis, as determined by animal
experiments, however, is not consistently beneficial in terms
of cancer prevention (Shamberger & Rudolph, 1966;
Wattenberg, 1972; Wattenberg, 1978; King & Otto, 1979; Ip,
1982a, b). It is possible that vitamin E can inhibit chemically
induced tumour development under certain conditions (Cook
& McNamara, 1980; McCay et al., 1981), but a reproducible
experimental model in which vitamin E consistently
suppresses neoplastic growth has not yet been found (McCay
et al., 1981; Ip, 1982a, b).
As found in a former experiment in our laboratories
(Aksoy et al., 1985) both toxicity (bone fractures, loss of
weight, peliosis cutis) and anti-tumour efficacy were found,
when a high dose of vitamin A palmitate ester (100,000IU
per 1,000kcal) was added to a diet containing a very low fat
level of 12% of total energy as fat. However, in a high-fat
group (45% energy as fat) neither toxicity nor tumour-
inhibitory activity following the same vitamin amounts were
observed.
To elucidate this discrepancy we examined the influence of
two levels of dietary fat in isocaloric diets, supplemented
with normal or tenfold higher amounts of vitamins A
(palmitate ester) and E on methylnitrosourea-induced rat
mammary tumorigenesis. The lower fat level was increased
to 25% energy as fat, since a very low dietary fat level of
12% energy is not encountered in human diets. Accordingly
the level of vitamin A was halved to a non-toxic level of
50,000 IU per 1,000kcal.
Specifically, we intended to answer the following
questions: (1) Can dietary vitamin A and E supplementation
at a non-toxic level suppress or block chemically induced
mammary tumour development? (2) How does the influence
of these fat-soluble vitamins on tumorigenesis correlate with
the dietary fat level?
Material and methods
Animals and tumour induction
Female Sprague Dawley rats (120) were purchased from the
Zentralinstitut fur Versuchstierzucht, Hannover, FRG, at an
age of 40 days. They were housed two per cage (Macrolon
cage III) in a temperature-controlled (21 +2C) and 12h
light/dark cycled room. On day 50 of life all animals were
H
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injected with 25mg of MNUkg-' via a tail vein to induce
mammary carcinomas.
Diets andfeeding
One day after tumour induction, until which a commercial
standard diet had been given (Altromin 1320, Lage, FRG),
the rats were randomly divided into 4 experimental groups
to receive one of the following diets which varied with
respect to their fat and vitamin content (Table I). The fat
composition of semisynthetic diets (Table II), which were
obtained from Unilever Research (Vlaardingen, The
Netherlands), was mixed according to the fatty acid profile
of the normal Western German diet (normal diet =ND).
Therefore, the fat of diets ND25 and ND45 (containing 25%
and 45% of the energy as fat, respectively) consisted of 75%
palm oil, 14% lard, and 11% sunflower seed oil. The ratio
of saturated fatty acids and mono- and polyunsaturated fatty
acids was 45%, 38% and 16%, respectively, in ND-diets.
The supplemented vitamin diets (ND25 +A/E and
ND45+A/E) contained 10 times more naturally occurring
vitamins than the normal standard rat-diets, while remaining
below the toxic level (50,000 IU vitamin A and 225 IU
vitamin E per 1,000kcal). The level of vitamin E was
considered adequate in satisfying the vitamin requirements
and preventing vitamin A oxidation in those rats fed a high
fat and high vitamin containing diet (Table I). Vitamin A
was added to the diets as vitamin A palmitate. The diets
were offered at a daily caloric supply of 50kcal per day and
rat 5 times a week. On the fifth day a 3-fold amount was
given. All fatty diets were kept in closed containers at
-20°C to minimize lipid peroxidation. Before feeding the
temperature of diets was brought up to room temperature.
All animals received tap water ad libitum.
Evaluation of tumour growth and termination ofstudy
All animals were inspected twice daily. The body weight
development and the occurrence and growth of mammary
carcinomas was recorded in weekly intervals. The tumour
size was estimated by measuring two vertical axes with
vernier calipers according to the formula a2 x b/2(a<b). All
animals were observed until termination of the study after 6
months of feeding, or were killed prematurely when found
moribund. After death rats were dissected and macro-
scopically examined. All tumours and visibly changed organs
were fixed in formalin for histological examination (Prof. D.
Komitowsky, Institute of Pathology, German Cancer
Research Center).
Statistical analysis
Estimates on the cumulative probability of tumour
manifestation times were made using the Kaplan-Meier
method; comparisons of censored animals between groups
were made using the log-rank test (Kalbfleisch & Prentice,
1979). Differences in tumour numbers were assessed accord-
ing to Dunn's comparisons of multiple rank sums (Dunn,
1964). Analysis of differential tumour growth was performed
using a nonparametric multivariate test, as described by
Table II Profile of fatty acids in semisynthetic diets
Diets
ND25 and ND45 and
Fatty acid ND25+A/E ND45+A/E
C 14:0 1.1 1.1
C 16:0 39.1 39.8
C 16:1 _ _
C 17:0 0.1 0.1
C 17:1 - _
C 18:0 5.4 5.4
C 18:1 37.9 37.5
C 18:2 15.5 15.3
C 18:3 0.2 0.2
C 20:0 0.3 0.3
C 20:1 0.3 0.2
C 20:2 - _
C 20:3
C 20:4 - -
C 22:0 0.1 0.1
C 22:1 - _
C 24:1 - _
Saturated fatty acids 46.1 46.8
Monounsaturated fatty acids 38.2 37.7
Polyunsaturated fatty acids 15.7 15.5
Total 100.0 100.0
Fat content (weight %) 10.3 21.6
Koziol and Donna (1981). The incidences of groups were
compared with Fishers Exact test. Comparisons of body
weight-data were made according to the F-test (Kalbfleisch
& Prentice, 1979).
Results
Body weight gain
The effect of supplemented vitamins A and E to diets,
different in the amount of fat, on the mean body weight gain
of methylnitrosourea-induced female SD-rats is shown in
Figure 1. Aside from the small differences at the beginning
of the experiment an almost congruent body weight gain
could be observed. The slight increase in variation following
week 11 was related to the occurrence of tumours. Neither
the dietary fat level nor the vitamin supplementation was
found to have a significant effect on body weight gain
according to the F-test.
Occurrence of tumours
The mean time of tumour manifestation of affected rats as
well as overall tumour manifestation time based on
maximum likelihood estimates is shown in Table III. The
tendency of rats fed with vitamin A and E supplemented
diets to show an increased tumour free time was not
significant according to the log-rank version of the Kaplan-
Meier method (Kalbfleisch & Prentice, 1979).
Table I Composition of diets
g/1OOg Diet en %a mgkcal 1
Experimental Carbo- Carbo-
group Protein hydrates Fat Cellulose Minerals Vitamins Protein hydrates Fat Cellulose Minerals Vitaminsb
ND25 23.9 57.2 10.4 5.8 2.3 0.4 24.0 51.0 25 15.0 5.4 1.0
ND25+A/E 23.8 57.2 10.3 5.8 2.3 0.6 24.0 51.0 25 15.0 5.4 1.7
ND45 27.7 40.9 21.6 6.7 2.6 0.4 24.0 31.0 45 15.0 5.4 1.0
ND45+A/E 27.6 40.8 21.6 6.7 2.6 0.7 24.0 31.0 45 15.0 5.4 1.7
aPercent of total energy; bContains 50.0001U vitamin A and 2251U vitamin E per I.OOOkcal for the diets ND25+A/E and ND45+A/E;
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Table III Influence of two different fat levels of diets supplemented with vitamins A and E on
manifestation time and tumour number of female SD-rats induced with methylnitrosourea
Mean tumour Number of
manifestation Overall tumour tumours per Total number
time of manifestation tumour bearing oftumours
Diet affected ratsa timea.b rat per group
ND25 13.5+5.1 17.6+2.2 2.1 +0.9c 43
ND25+A/E 14.3 +4.6 17.7+1.8 2.0+0.9 41
ND45 12.5+3.5 14.4+1.3 2.1 + 1.2 52
ND45+A/E 13.4+ 3.9 17.5+2.0 3.0+ 1.6 63
aWeeks+s.d.; bMaximum likelihood estimates, assuming a (right-censored) log normal
distribution of tumour manifestation times; c+s.d.
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Figure 1 Effects of supplementation of vitamin
different amounts of fat on body weight devel
induced with methylnitrosourea.
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* ND 25
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uniform but not significant in both groups fed with the
different fat levels. The mortality was significantly lower in
the group fed with the ND25 +A/E-diet compared to
ND45+A/E (P=0.026, according to Fishers Exact test. In
view of the disproportionally low number of 1 dead animal
in the ND25 +A/E-group as related to 5, 9, and 7 dead
animals in the ND25, ND45, and ND45 +A/E-groups,
respectively, this significance might be interpreted as a
runaway value rather than being a treatment effect.
Tumour numbers
* ND 45 The number of tumours per group (Table III) is the result of ---.--.--------- tumour incidence (Figure 2) and number of tumours per oND 45 + A/E tumour bearing rat (Table III). Both the total number of
tumours per group and the number of tumours per tumour
20 25 bearing rat insignificantly increased with rising level of fat.
Vitamin A and E supplementation effected a somewhat
Is A and E and reduced tumour number in the low fat group and enhanced
lopment in rats the number of tumours per rat as well as the total number of
tumours in the groups fed the high fat diet which, however,
was not significant.
Tumour growth and histology
The rats fed with 45en% of fat in their diets produced a
greater tumour volume than the group fed with 25en% of
fat which can be seen in Figure 3. This effect, however, was
not significant. Vitamin administration resulted in a higher
mean tumour volume when supplemented to the low fat diet
and conversely caused a smaller tumour volume when given
with the high fat diet, which was insignificant, as well.
Histological evaluation of mammary lesions revealed >90%
to be carcinomas, mainly of the tubulo-papillary type. There
ND25 ND25+A/E
Diets
25
ND45 ND 45+ A/E
Figure 2 Influence of vitamins A and E supplemented to diets
containing two different fat levels on % tumour incidence (El)
and % mortality (El) of methylnitrosourea induced female SD-
rats.
Development of tumour incidence and mortality
Both the tumour incidence and mortality, due to tumour
growth, increased slightly with rising fat content, which is
shown in Figure 2. This effect, however, was not significant.
Supplementation of vitamin A and E had no homogeneous
influence on the incidence of mammary tumours. In com-
parison to ND25 the ND25 +A/E-group showed a slight
increase in the number of tumour bearing rats whereas in the
groups receiving the diet with 45en% of fat the vitamin
supplementation decreased tumour incidence. These effects
were not significant (Fishers Exact test). The diminishing
effect of vitamin supplementation on mortality data was
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Figure 3 Tumour growth development of methylnitrosourea
induced mammary carcinomas in SD-rats; comparison of the
influence of two different fat levels with or without vitamin A
and E supplementation. Indicated are the mean tumour volumes
and selected 95% confidence limits of diets ND25 and ND45.
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was no significant difference in the distribution of adenomas
(10% of all tumours) between groups.
Discussion
The present study was basically designed to elucidate the
effects of dietary vitamin A and E supplementation on
chemically induced mammary tumorigenesis and the
variation in efficacy if these fat soluble vitamins are added to
diets of different fat levels. The principal observations of this
experiment are: (1) Vitamin A and E supplementation
showed no significant chemopreventive effect against
mammary tumour development. (2) This result was
independent from the supplied fat level of the respective diet.
(3) The fat content per se did not significantly influence
mammary tumorigenesis.
The mammary gland is known to be a target organ of
retinyl ester activity; according to Moon (1983) retinyl
acetate exerts an inhibitory effect on ductal branching, end
bud proliferation and DNA synthesis in this organ.
However, the utility of vitamin A as an anticarcinogenic
treatment in mammary neoplasia is contested since some
researchers found beneficial effects in MNU- (Moon et al.,
1977) and in DMBA- (Welsch & De Hoog, 1983; Zile et al.,
1986) induced mammary tumorigenesis. The reported signifi-
cant decrease in body weight gain and the general unhealthy
condition of the animals, however, lead to the conclusion,
that the observed beneficial results must be regarded with
consideration of the obvious toxic side effects in some of
these studies (Welsch et al., 1980; McCormick & Moon,
1982; Thompson et al., 1986).
In all of these studies vitamin A was administered as
retinyl acetate. In this experiment, vitamin A was added to
the diets as palmitate ester, because this form of vitamin A is
the main source of dietary vitamin A intake in humans.
Since retinyl esters, generally, are hydrolysed to retinol
before being absorbed by intestinal mucosal cells, no differ-
ence in the released active vitamin has to be expected,
regardless whether retinol, esterified to acetate or palmitate,
is administered to the diet (Lotan, 1980).
Other studies, which showed no significant effects on
mammary tumorigenesis after vitamin A supplementation,
administered either as palmitate ester (Schmahl et al., 1972)
or as acetate ester (Thompson & Ronan, 1983) are in
agreement with the results of the present experiment.
Remarkably, in addition to these findings, results from
other tumour systems demonstrate even enhanced tumori-
genesis following retinoid administration (Polliack & Levij,
1969; Quander et al., 1985). The latter findings could raise
concern about the potential hazard in the pharmacological
use of vitamin A.
Concerning vitamin E our study corresponds with other
experiments, which resulted in no beneficial effect on tumori-
genesis (Shamberger & Rudolph, 1966; Wattenberg, 1972;
King & Otto, 1979; Ip, 1982a, b). Inhibitory effects on
chemically induced tumour development was found only
under certain conditions (Cook & McNamara, 1980; McCay
et al., 1981).
In a former experiment from our laboratory a high
vitamin A palmitate supplementation, which was above the
toxic level, decreased tumorigenesis, when given with a diet
containing 12% energy as fat, only (Aksoy et al., 1985).
Although vitamin A toxicity and cancer preventive activity
do not necessarily coincide, the tumour inhibitory effect as
well as the toxic side effects were completely abolished, when
vitamin A was supplemented to a high fat diet (45en%).
Similarly to this observation Aylsworth et al. (1986) found a
significantly decreased tumour size after feeding retinyl
acetate with a low fat diet, but no effect when supplementary
to a high fat diet. As derived from these studies it seems that
both the toxic side effects and the beneficial efficacy of
vitamin A are dependent upon a low dietary fat level.
Because a fat content of 12en% is not encountered in
human diets, this study was set up to examine whether
beneficial effects could be observed when the low fat level
was adapted to the human situation and when the vitamin
supplement was below the toxic level (50,000 IU per
1,000kcal). Interestingly, the vitamin supplementation did
not show a significant effect on tumorigenesis at either fat
level.
Apart from this, the fat level per se did not show a
significant effect on tumour development (Figure 2, Table
III), which is in full agreement with the results of a parallel
study (Beth et al., 1987).
Summarizing this discussion of the different experimental
results we conclude that the naturally occurring vitamins A
and E are not able to inhibit the process of carcinogenesis in
the mammary gland specifically, except for very low dietary
fat levels. Observed beneficial effects were connected with
considerable toxic side effects of the compounds. An
inhibitor of carcinogenesis, however, would have to be taken
by individuals for many years. Thus even a low toxicity
could outweigh any benefits. Therefore the ultimate goal of
these experimental studies, to find a non-toxic pharmaco-
logical means which effectively inhibits the development of
human mammary cancer, seems not to be reached with
naturally occurring vitamins A and E at dietary fat levels
encountered in human beings.
The authors gratefully acknowledge the careful technical assistance
of Mrs A. Danisman.
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